Neoadjuvant chemotherapy in the conservative management of breast cancer: a study of 252 patients.
Jacquillat
C
C
Department of Medical Oncology (SOMPS), Hôpital de la Salpétrière, Paris, France.
Weil
M
M
Auclerc
G
G
Auclerc
M F
MF
Khayat
D
D
Baillet
F
F
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D011379:Prognosis; D011897:Random Allocation; D013629:Tamoxifen / Q000008:administration & dosage; D013852:Thiotepa / Q000008:administration & dosage; D014747:Vinblastine / Q000008:administration & dosage
D013629:Tamoxifen; D014747:Vinblastine; D004317:Doxorubicin; D013852:Thiotepa; D005472:Fluorouracil; D008727:Methotrexate